YU4101A - Novi postupci za identifikovanje liganada i ciljnih biomolekula - Google Patents
Novi postupci za identifikovanje liganada i ciljnih biomolekulaInfo
- Publication number
- YU4101A YU4101A YU4101A YU4101A YU4101A YU 4101 A YU4101 A YU 4101A YU 4101 A YU4101 A YU 4101A YU 4101 A YU4101 A YU 4101A YU 4101 A YU4101 A YU 4101A
- Authority
- YU
- Yugoslavia
- Prior art keywords
- identification
- peptide
- methods
- rna
- identified
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 5
- 239000003446 ligand Substances 0.000 title 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 3
- 102000004190 Enzymes Human genes 0.000 abstract 2
- 108090000790 Enzymes Proteins 0.000 abstract 2
- 239000003596 drug target Substances 0.000 abstract 2
- 230000000694 effects Effects 0.000 abstract 2
- 229940088598 enzyme Drugs 0.000 abstract 2
- 238000012216 screening Methods 0.000 abstract 2
- 229940122644 Chymotrypsin inhibitor Drugs 0.000 abstract 1
- 101710137926 Chymotrypsin inhibitor Proteins 0.000 abstract 1
- 108020004414 DNA Proteins 0.000 abstract 1
- 240000005979 Hordeum vulgare Species 0.000 abstract 1
- 235000007340 Hordeum vulgare Nutrition 0.000 abstract 1
- 108091028043 Nucleic acid sequence Proteins 0.000 abstract 1
- 244000061456 Solanum tuberosum Species 0.000 abstract 1
- 235000002595 Solanum tuberosum Nutrition 0.000 abstract 1
- 239000003153 chemical reaction reagent Substances 0.000 abstract 1
- 239000003541 chymotrypsin inhibitor Substances 0.000 abstract 1
- 229940042399 direct acting antivirals protease inhibitors Drugs 0.000 abstract 1
- 238000009509 drug development Methods 0.000 abstract 1
- 239000002532 enzyme inhibitor Substances 0.000 abstract 1
- 239000013604 expression vector Substances 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
- 230000003993 interaction Effects 0.000 abstract 1
- 150000002611 lead compounds Chemical class 0.000 abstract 1
- 229940126601 medicinal product Drugs 0.000 abstract 1
- 239000000137 peptide hydrolase inhibitor Substances 0.000 abstract 1
- 230000009466 transformation Effects 0.000 abstract 1
- 230000001131 transforming effect Effects 0.000 abstract 1
Landscapes
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Pronalazak obezbedjuje postupke za identifikovanje bioloski aktivnih biomolekula. U jednom vidu pronalaska, jedan bioloski aktivan biomolekul kao sto je RNK ili neki peptid identifikovan je ugradnjom nasumice modifikovanih nukleotidnih sekvenci u jednu resetku koju sacinjava jedan modulator delovanja enzima, transformisanjem u sustini identicnih celija domacina napred dobijenim strukturama i pretrazivanjem tansformisanih celija da bi se identifikovale one kod kojih je promenjeno jedno unapred izabrano fenotipsko svojstvo. Potom se nasumice modifikovana DNK izdvaja iz fenotipski promenjenih celija i odredjuje se peptid i/ili RNK kodiran nasumice modifikovanom sekvencom. Sa svoje strane, partneri za medjusobno delovanje koji su moguci ciljni lekovi identifikovani su i izdvojeni koriscenjem peptida i/ili RNK kao dela afinitetnih reagensa. Jedna preporucljiva resetka je izvedena od krompirovog inhibitora I familije proteinskih inhibitora a kao primer prikazan je jecmeni inhibitor 2A (Cl-2A) himotripsina. Drugi vid pronalaska odnosi se na identifikaciju novih enzimskih inhibitora koristeci u sustini isti pristup, ali uz specificno pretrazivanje promena delovanja ciljnih enzima. Takodje su prikazani postupci izvodjenja relevantnih vektora transformacija i izrazavanja kao i postupci za identifikovanje vodecih jedinjenja i ciljnih lekova za primenu u razvoju lekova. Konacno, u opseg pronalaska takodje spada i postupak za pripremanje jednog lekovitog proizvoda.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DKPA199800956 | 1998-07-20 | ||
| US9486898P | 1998-07-29 | 1998-07-29 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| YU4101A true YU4101A (sh) | 2005-06-10 |
Family
ID=27675497
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| YU4101A YU4101A (sh) | 1998-07-20 | 1999-07-16 | Novi postupci za identifikovanje liganada i ciljnih biomolekula |
Country Status (2)
| Country | Link |
|---|---|
| YU (1) | YU4101A (sh) |
| ZA (1) | ZA200100195B (sh) |
-
1999
- 1999-07-16 YU YU4101A patent/YU4101A/sh unknown
-
2001
- 2001-01-08 ZA ZA200100195A patent/ZA200100195B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ZA200100195B (en) | 2002-01-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL346126A1 (en) | Novel methods for the identification of ligand and target biomolecules | |
| Raines | Ribonuclease a | |
| Fiers et al. | Complete nucleotide sequence of bacteriophage MS2 RNA: primary and secondary structure of the replicase gene | |
| US5821063A (en) | Methods for sequencing polymers using mass spectrometry | |
| Wower et al. | Labeling the peptidyltransferase center of the Escherichia coli ribosome with photoreactive tRNA (Phe) derivatives containing azidoadenosine at the 3'end of the acceptor arm: a model of the tRNA-ribosome complex. | |
| Meldal | The one‐bead two‐compound assay for solid phase screening of combinatorial libraries | |
| WO1999057311A3 (en) | Novel method for the identification of clones conferring a desired biological property from an expression library | |
| WO2003099999A3 (en) | Generation and selection of protein library in silico | |
| KR100204360B1 (en) | A method for identifying a polynucleotide molecule having a selected nucleic acid sequence from a library of random or semi-random polynucleotide molecules | |
| EP0777750A4 (en) | HIGH SALES METHOD FOR DETECTING SEQUENCES OR GENETIC CHANGES IN NUCLEIC ACIDS | |
| WO1996036986A1 (en) | Methods and apparatus for sequencing polymers with a statistical certainty using mass spectrometry | |
| WO2002002740A3 (en) | Methods and compositions for determining gene function | |
| WO1998014596A3 (en) | Disease associated protein tyrosine phosphatases | |
| GB9722320D0 (en) | Human cell cycle checkpoint proteins | |
| WO2002086081A3 (en) | Methods and systems for identifying proteins | |
| Burgos et al. | Analysis of the activation process of porcine procarboxypeptidase B and determination of the sequence of its activation segment | |
| St. Hilaire et al. | Solid-Phase Library Synthesis, Screening, and Selection of Tight-Binding Reduced Peptide Bond Inhibitors of a Recombinant Leishmania m exicana Cysteine Protease B | |
| Antal et al. | Specificity assay of serine proteinases by reverse-phase high-performance liquid chromatography analysis of competing oligopeptide substrate library | |
| WO2002044409A3 (en) | Substrate linked directed evolution (slide) | |
| WO2001053531A3 (en) | Osteoarthritis tissue derived nucleic acids, polypeptides, vectors, and cells | |
| WO2004033485A3 (en) | Nucleic acid supported protein complementation | |
| WO2003073351A3 (en) | Screening process | |
| US20040023292A1 (en) | Method and reagent for the detection of proteins and peptides | |
| Ishigami et al. | The origin of the genetic code | |
| EP0811696A3 (en) | Method to obtain nucleotide sequence using randomly primed amplification |